Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis

Filename 541. Staubach et al., Lige in adolescents CSU, PAI 2023.pdf
Filesize 2.06 MB
Version o.541
Date added August 21, 2023
Downloaded 0 times
Category Original Work
Authors Staubach, P. Alvaro-Lozano, M., Sekerel, B. E., Maurer, M., Ben-Shoshan, M., Porter, M., Hua, E., Ji, Y., Burciu, A., Savelieva, M., Severin, T., Drollmann, A., and Bienczak, A.
Citation Staubach, P. Alvaro-Lozano, M., Sekerel, B. E., Maurer, M., Ben-Shoshan, M., Porter, M., Hua, E., Ji, Y., Burciu, A., Savelieva, M., Severin, T., Drollmann, A., and Bienczak, A.: Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis. Pediat. Allergy Immunol. 2023: 34; e13982.
Corresponding authors Drollmann, A.
DocNum o.541
DocType PDF
IF TBD (IF 2022: 4.40)
Publisher Pediat. Allergy Immunol.
ReleaseDate 2023
 

(Last update: 12.2023)

Number of original publications in peer-reviewed journals:580
Number of reviews in peer-reviewed journals:210
Number of publications (original work and reviews) in peer-reviewed journals:790
Cumulative IF for original publications in peer-reviewed journals:4196.39
Cumulative IF for reviews in peer-reviewed journals:1409.32
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:5605.71
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023)36836

Download-Information

To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.